BRAF and thyroid gland papillary carcinoma: These 5 molecular alterations are frequently represented in malignant thyroid nodules, especially BRAF. Twenty-two of 24 ITNs carrying the BRAFV600E mutation were diagnosed as papillary thyroid cancer.